文献速递神经肿瘤脊柱脊髓外科

脊髓高级别脑膜瘤的临床特征与管理差异

Clinical characteristics and management differences for grade II and III spinal meningiomas.
PubMed 文献 · J Neurooncol · 2021-05-10

该研究回顾1988至2018年间188例手术切除的脊髓脑膜瘤患者,其中16例为高级别(II级15例、III级1例),中位随访8.0年,复发率47.1%、死亡率18.8%。单因素分析显示辅助放疗和胸段受累与较低复发率相关,男性与较高复发率相关。

要点

  • 脊髓高级别脑膜瘤(II/III级)罕见,占本组8.5%。
  • 高级别肿瘤复发率47.1%、死亡率18.8%,需密切随访。
  • 辅助放疗及胸段受累与较低复发率相关,男性与较高复发相关。

核心结论

  • 高级别脊髓脑膜瘤临床结局存在差异,复发问题尤为突出。
  • 辅助放疗和胸段受累与较低复发率相关,男性与较高复发率相关。

研究设计与样本

  • 经IRB批准的回顾性机构电子病历研究,纳入1988至2018年手术切除且病理证实的脊髓脑膜瘤患者。
  • 共188例,其中II级15例、III级1例;采用Kaplan-Meier曲线分析进展/复发时间。

主要发现

  • 188例中172例(91.5%)为I级,16例(8.5%)为高级别(II级15例、III级1例)。
  • 中位随访8.0年(IQR 5.1-13.0),死亡率18.8%(n=3),复发率47.1%(n=8)。
  • 单因素分析:辅助放疗和胸段受累与较低复发率相关,男性与较高复发率相关。

关键数值与推荐

  • 高级别脊髓脑膜瘤定义依据WHO分类:II级为不典型,III级为间变性。
  • 中位随访8.0年(IQR 5.1-13.0),复发率47.1%(n=8),死亡率18.8%(n=3)。

临床怎么用

  • 对高级别脊髓脑膜瘤术后应加强复发监测,尤其男性患者。
  • 辅助放疗和胸段受累与较低复发率相关,可作为个体化治疗参考。

局限性

  • 回顾性单中心研究,高级别病例数少(n=16),结果需谨慎解读。
  • 单因素分析未校正混杂因素,关联性不等于因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The majority of spinal meningiomas are grade I tumors, as defined by World Health Organization (WHO) classification making atypical (grade II) or anaplastic (grade III) tumors extremely rare lesions to encounter in clinical practice. Here, we present our institutional experience of management of grade II and III spinal meningiomas. METHODS: Following IRB approval, we queried all available institutional electronic medical records for patients undergoing surgical resection of pathology-proven spinal meningiomas, with further review of patients with grade II and III. Variables of interest included age, sex, histological type, tumor size, symptoms at baseline, treatment characteristics, symptom resolution at the last follow-up, recurrence, NF-2 status, concurrent intracranial meningioma, and mortality. Kaplan Meier curves were constructed to study time to progression/recurrence. RESULTS: A total of 188 patients undergoing surgical resection of spinal meningioma between 1988 and 2018 were identified. Among those, 172 (91.5%) patients had grade I meningioma and 16 (8.5%) patients had high grade meningiomas [grade II (15) and III (1)]. Over a median (IQR) follow-up of 8.0 years (5.1-13.0), mortality and recurrence rates were 18.8% (n = 3) and 47.1% (n = 8), respectively. In univariate analysis, adjuvant radiotherapy and thoracic segment involvement were associated with lower rates of recurrence while male sex was associated with a higher rate of recurrence. CONCLUSIONS: Results showed variations in clinical outcomes for patients with high grade spinal meningiomas, especially the recurrence. Adjuvant radiotherapy and thoracic segment involvement was associated with lower rates of recurrence while recurrence ocurred at a higher rate in males.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Krauss WE, Yolcu YU, Alvi MA, et al. Clinical characteristics and management differences for grade II and III spinal meningiomas. J Neurooncol. 2021. PMID: 33973145. doi:10.1007/s11060-021-03771-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。